TITLE:
Comparing Lifestyle Convenience of Multiple Daily Injection and Continuous Subcutaneous Insulin Infusion
AUTHORS:
Ikuko Nishio
KEYWORDS:
Insulin Infusion Systems, Lifestyle, Disease Management, Multiple Daily Injection, Type 1 Diabetes, Women’s Health
JOURNAL NAME:
Open Journal of Nursing,
Vol.7 No.12,
December
8,
2017
ABSTRACT: Aim: This study investigated the lifestyle convenience of Insulin therapy for
adult women patients with type 1 diabetes. Methods: Participants were
type 1 diabetes adult women patients who switched from multiple daily injection
(MDI) therapy to Continuous Subcutaneous Insulin Infusion (CSII) therapy. We
conducted semi-structured interviews with participants. To analyze,
we referenced the classification table of Hamada’s study comparing the
usefulness of both the NovoPen? and CSII. Semi-structured interviews were
conducted with the research subjects. The questions focused mainly on diabetes
management, instrument operation, everyday life, and social, psychological and
lifestyle convenience aspects during MDI and CSII. Results: Research
subjects were 4 women patients with type 1 diabetes. The average age was 35.3 ±
6.24 (SE) years old. Participants were undergoing MDI therapy; however, in the
middle, they switched to CSII therapy. CSII therapy is convenient in terms of
diabetes management, social and psychological. MDI therapy is convenient in
terms of instrument operation and daily life. Compared to MDI therapy, CSII
therapy is less convenient in terms of instrument operation and everyday life.
However, since CSII therapy has more stable HbA1c and blood glucose levels
compared to MDI therapy, it is more convenient in terms of social and
psychological aspects and reduces those burdens. About economy CSII therapy,
patients paid about 5000 yen more per month compared to MDI therapy. Conclusion: It is believed that patients prioritize therapeutic effects, and choose
CSII, which is stable in psychological and social aspects, even though it is
inconvenient with life.